Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6799665 | 0.84 | MMP1 (0.40) | — | |
| SCHEMBL6800871 | 0.84 | ALDH1A1 (0.37) | KMT2AMEN1 | |
| SCHEMBL6807936 | 0.71 | MMP1 (0.42) | KMT2APTPN1 | |
| SCHEMBL6807429 | 0.68 | PTGER2 (0.40) | KMT2A | |
| SCHEMBL16468409 | 0.67 | CYP1A2 (0.53) | KMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL13638756 | 0.65 | ALDH1A1 (0.50) | KMT2AMEN1 | |
| SCHEMBL20379453 | 0.65 | KMT2A (0.57) | KMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL11826492 | 0.65 | CRHBP (0.48) | KMT2AMEN1CRHBPCRHR2 | |
| SCHEMBL28783481 | 0.65 | CA12 (0.57) | KMT2A | |
| SCHEMBL19332540 | 0.63 | CA1 (0.58) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | KMT2A 2262/4885MEN1 4379/4885CRHBP 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.